Table 2.
Demographic data, clinical, and laboratory findings of the groups with infection eradication and infection persistence.
| Variable | Infection Eradication n = 38 | Infection Persistence n = 11 | p-Value |
|---|---|---|---|
| Mean age, y * | 69.1 ± 10.7 | 71 ± 12.4 | 0.5 |
| CRP at admission (mg/L) * | 14.3 ± 17 | 49.4 ± 60 | 0.003 |
| CCI * | 4 ± 2.8 | 4.8 ± 3 | 0.37 |
| Mortality after first stage ⧫ | |||
| Ninety days | 0 (0) | 5 (46) | <0.001 |
| Last follow-up | 6 (16) | 6 (54) | 0.02 |
| Infection subgroups | |||
| Definitive | 11 (29) | 5 (46) | 0.47 |
| Probable | 22 (58) | 3 (27) | 0.1 |
| Possible | 5 (13) | 3 (27) | 0.4 |
| Polymicrobial shoulder PJI ⧫ | 11 (29) | 3 (27) | 1.0 |
| Culture-negative shoulder PJI ⧫ | 5 (13) | 3 (27) | 0.4 |
* The values are given as the mean and the standard deviation. ⧫ The values are given as the number with the percentage of the group in parentheses. CCI: Charlson comorbidity index.